Inventor · disambiguated record
Philip T. Liu
Also filed as: LIU PHILIP · LIU PHILIP T
10 granted patents·10 pending applications·13 citations·filing 2018–2025
83Inventor score
Top patents by PatentIndex Score
20 records- 0192US11298414B2Cellular adjuvants for viral infectionNANTBIO INC·Filed 2019·Granted Apr 12, 2022·6 cites·8 claims
- 0291US10814011B1Anti-B7-H4 antibodies and methodsNANTBIO INC·Filed 2018·Granted Oct 27, 2020·7 cites·26 claims
- 0389US12350323B2Cellular adjuvants for viral infectionNANTBIO INC·Filed 2024·Granted Jul 8, 2025·0 cites·18 claims
- 0488US12329809B2Cellular adjuvants for viral infectionNANTBIO INC·Filed 2024·Granted Jun 17, 2025·0 cites·18 claims
- 0581US2025262288A1Cellular Adjuvants for Viral InfectionNANTBIO INC·Filed 2025·Application pending·0 cites
- 0680US12274748B2Adenoviral vector transduced apheresis productIMMUNITYBIO INC·Filed 2024·Granted Apr 15, 2025·0 cites·6 claims
- 0779US12220452B2Cellular adjuvants for viral infectionNANTBIO INC·Filed 2022·Granted Feb 11, 2025·0 cites·19 claims
- 0876US2023406918A1Method of treatment of a tumor with il-8 antibodyNANTBIO INC·Filed 2023·Application pending·0 cites
- 0973US2023270879A1Anti-B7-H4 Antibodies And MethodsNANTBIO INC·Filed 2023·Application pending·0 cites
- 1072US12409135B2Neoepitope vaccine delivery vehicle and methods of making the sameIMMUNITYBIO INC·Filed 2022·Granted Sep 9, 2025·0 cites·7 claims
- 1169US2025339369A1Neoepitope Vaccine Delivery Vehicle and Methods of Making the SameIMMUNITYBIO INC·Filed 2025·Application pending·0 cites
- 1268US11773158B2Method of treatment of a tumor with an IL-8 antibodyNANTBIO INC·Filed 2020·Granted Oct 3, 2023·0 cites·12 claims
- 1368US11672873B1Anti-B7-H4 antibodies and methodsNANTBIO INC·Filed 2020·Granted Jun 13, 2023·0 cites·20 claims
- 1462US2025242025A1Adenoviral Vector Transduced Apheresis ProductIMMUNITYBIO INC·Filed 2025·Application pending·0 cites
- 1556US12448638B2Enzyme based system for production of messenger RNA with increased transfection efficiencyIMMUNITYBIO INC·Filed 2022·Granted Oct 21, 2025·0 cites·7 claims
- 1652US2022187279A1Rapid t-cell assay for sars-cov-2IMMUNITYBIO INC·Filed 2021·Application pending·0 cites
- 1751US2022125866A1Pharmaceutical compositions to enhance phagocytosis without inflammationNANTCELL INC·Filed 2020·Application pending·0 cites
- 1848US2022289824A1TGF-beta TRAPNANTBIO INC·Filed 2020·Application pending·0 cites
- 1947US2020024326A1Tnf-type receptor-ligand fusion proteins and methodsNANTBIO INC·Filed 2019·Application pending·0 cites
- 2041US2020282037A1Bacterial vaccineNANTBIO INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philip T. Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →